We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Brandy Heckman-Stoddard

Brandy M. Heckman-Stoddard PhD, MPH

Chief, Breast and Gynecologic Cancer Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Rockville, Maryland

Brandy M. Heckman-Stoddard, PhD, MPH, is Chief of the Breast and Gynecologic Cancer Research Group in the Division of Cancer Prevention at the National Cancer Institute (NCI).

Dr. Heckman-Stoddard’s research portfolio focuses on interventions to reduce breast and gynecologic cancer risk as well as the development of surrogate biomarkers.

She serves as the NCI Project Scientist for the Diabetes Prevention Program Outcomes Study in collaboration with the National Institute of Diabetes and Digestive and Kidney Diseases examining the impact of metformin and lifestyle intervention on cancer risk.

Disclosures

Dr. Heckman-Stoddard has no relevant disclosures.

Recent Contributions to PracticeUpdate:

  1. Weight Loss Intervention and Cancer Risk in T2DM